1,098
Views
8
CrossRef citations to date
0
Altmetric
Drug Evaluations

Apremilast as a treatment for psoriasis

, BS, , MD, , BA & , MD PhD
Pages 1761-1770 | Published online: 20 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Cholleti Vijaykumar, Yalavarti Ravindra Kumar, Pasula Aparna & Vishnu Murthy Marisetti. (2022) Enantioselective Green HPLC Method for Simultaneous Determination of Enantiomer, and Potential Impurities in Apremilast Drug Substance. Analytical Chemistry Letters 12:6, pages 691-714.
Read now
Małgorzata Mazur, Jacek Karczewski, Martha Lodyga, Ryszard Żaba & Zygmunt Adamski. (2015) Inhibitors of phosphodiesterase 4 (PDE 4): A new therapeutic option in the treatment of psoriasis vulgaris and psoriatic arthritis. Journal of Dermatological Treatment 26:4, pages 326-328.
Read now
Arash Taheri, Laura F Sandoval, Sara Moradi Tuchayi, Hossein Alinia, Parisa Mansoori & Steven R Feldman. (2014) Emerging treatment options for psoriasis. Psoriasis: Targets and Therapy 4, pages 27-35.
Read now

Articles from other publishers (5)

Prashantkumar K. Parmar & Arvind K. Bansal. (2020) Novel nanocrystal-based formulations of apremilast for improved topical delivery. Drug Delivery and Translational Research 11:3, pages 966-983.
Crossref
Wenjiang Cao, Na Hu, Yong Yuan, Jiang Cheng, Xinhong Guo, Yanfang Wang, Xinchun Wang & Ping Hu. (2017) Effects of Tilianin on Proliferation, Migration and TGF-β/Smad Signaling in Rat Vascular Smooth Muscle Cells Induced with Angiotensin II. Phytotherapy Research 31:8, pages 1240-1248.
Crossref
Garry G. Graham & Kevin D. Pile. 2016. Compendium of Inflammatory Diseases. Compendium of Inflammatory Diseases 1079 1084 .
Jennifer C Cather & Elizabeth J Horn. (2015) Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies. Clinical Investigation 5:9, pages 777-791.
Crossref
Yong Liu, Simon Zhou, James Nissel, Anfan Wu, Henry Lau & Maria Palmisano. (2014) The pharmacokinetic effect of coadministration of apremilast and methotrexate in individuals with rheumatoid arthritis and psoriatic arthritis. Clinical Pharmacology in Drug Development 3:6, pages 456-465.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.